NCT00245479View on ClinicalTrials.gov

A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis

PHASE4CompletedINTERVENTIONAL
Enrollment

802

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

September 30, 2005

Study Completion Date

November 30, 2006

Conditions
Nocturnal Enuresis
Interventions
DRUG

Primary nocturnal enuresis

Desmopressin

Trial Locations (1)

75674

Foundation Hospital Saint Joseph, 185, rue Raymond Losserand, Paris

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT00245479 - A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis | Biotech Hunter | Biotech Hunter